Wake Up Wall Street (SPY) (QQQ) (SPX): Is it 'no time to die' for the equity market?
Premium|You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
Your coupon code
FXS75
Here is what you need to know on Monday, October 4:
No Time to Die is kicking up a storm in the UK and is due to do the same for the US when it is out on Thursday, so AMC apes get ready for some strong audience numbers if the UK experience is anything to go by. The equity market does feel like it is time to die though, despite a modest dead cat bounce on Friday. Things again look bleak on Monday (they always do!) if European markets are anything to go by. President Biden's much touted infrastructure deal is struggling for support just when many of the beneficiary stocks could do with a boost. Lawmakers also have to avoid the US failing to meet its debt burden, which kind of overshadows Evergrande's worries. But then the US is unlikely to default, whereas Evergrande might have some sort of controlled restructuring.
The dollar meanwhile continues to take a breather following last week's yield-induced run. It is currently trading at 1.1640 now versus the euro. Gold is at $1,754 and Oil at $76. Bitcoin is lower at $47,700, while the US 10-Year yield is also down at 1.48%. VIX is up 6% to 22.58.
See forex today
European markets are lower: FTSE -0.4%, Dax -0.1% and Eurostoxx -0.7%.
US futures are lower: S&P -0.3%, Dow -0.3% and Nasdaq -0.4%.
Wall Street (SPY) top news
The US to resume tariff exclusion procedure for Chinese imports.
UK wants to renegotiate the exit agreement with the EU, specifically over Northern Ireland.
UK admits a UK-US trade agreement could be 10 years away.
German electricity wholesale price reaches a record high.
Tesla (TSLA) up in premarket by 2% on strong delivery numbers, see here.
Evergrande raising up to $5 billion cash from asset sales.
Facebook (FB) whistleblower gives negative interview to CBS 60 minutes.
BioNTech (BNTX), Pfizer (PFE), Moderna (MRNA), Novavax (NVAX) are still down after Merck's (MRK) covid pill results on Friday.
Merck (MRK) up 4% in premarket on SVB price target rise and continued follow through from Friday.
Guardent Health (GH): Bloomberg reports company not buying NeoGenomics.
General Motors (GM) up 3% premarket. Company announces strategic supplier agreement with Wolfspeed for silicon carbide.
NetApp (NTAP) to acquire Cloudchecker.
Delta (DAL) reinstates Q3 revenue forecasts.
Southwest (LUV): Barclays upgraded it.
Proctor and Gamble (PG): Deutsche Bank ups price target.
Hasbro (HAS): Stifel lowers price target.
Upgrades, downgrades and premarket movers
Source: Benzinga Pro
Economic releases
Here is what you need to know on Monday, October 4:
No Time to Die is kicking up a storm in the UK and is due to do the same for the US when it is out on Thursday, so AMC apes get ready for some strong audience numbers if the UK experience is anything to go by. The equity market does feel like it is time to die though, despite a modest dead cat bounce on Friday. Things again look bleak on Monday (they always do!) if European markets are anything to go by. President Biden's much touted infrastructure deal is struggling for support just when many of the beneficiary stocks could do with a boost. Lawmakers also have to avoid the US failing to meet its debt burden, which kind of overshadows Evergrande's worries. But then the US is unlikely to default, whereas Evergrande might have some sort of controlled restructuring.
The dollar meanwhile continues to take a breather following last week's yield-induced run. It is currently trading at 1.1640 now versus the euro. Gold is at $1,754 and Oil at $76. Bitcoin is lower at $47,700, while the US 10-Year yield is also down at 1.48%. VIX is up 6% to 22.58.
See forex today
European markets are lower: FTSE -0.4%, Dax -0.1% and Eurostoxx -0.7%.
US futures are lower: S&P -0.3%, Dow -0.3% and Nasdaq -0.4%.
Wall Street (SPY) top news
The US to resume tariff exclusion procedure for Chinese imports.
UK wants to renegotiate the exit agreement with the EU, specifically over Northern Ireland.
UK admits a UK-US trade agreement could be 10 years away.
German electricity wholesale price reaches a record high.
Tesla (TSLA) up in premarket by 2% on strong delivery numbers, see here.
Evergrande raising up to $5 billion cash from asset sales.
Facebook (FB) whistleblower gives negative interview to CBS 60 minutes.
BioNTech (BNTX), Pfizer (PFE), Moderna (MRNA), Novavax (NVAX) are still down after Merck's (MRK) covid pill results on Friday.
Merck (MRK) up 4% in premarket on SVB price target rise and continued follow through from Friday.
Guardent Health (GH): Bloomberg reports company not buying NeoGenomics.
General Motors (GM) up 3% premarket. Company announces strategic supplier agreement with Wolfspeed for silicon carbide.
NetApp (NTAP) to acquire Cloudchecker.
Delta (DAL) reinstates Q3 revenue forecasts.
Southwest (LUV): Barclays upgraded it.
Proctor and Gamble (PG): Deutsche Bank ups price target.
Hasbro (HAS): Stifel lowers price target.
Upgrades, downgrades and premarket movers
Source: Benzinga Pro
Economic releases
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.